Clinical Trial Update: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating next-generation sensors and algorithms for diabetes management has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | NA | Status: WITHDRAWN